Winners revealed – Most Valuable Collaboration, Most Valuable Breakthrough/Discovery, Most Valuable Data & Insights Initiative & Most Valuable HCP Initiative 
We are delighted to celebrate the finalists and reveal the winners of these 4 categories in this free article. 
The winner of the Most Valuable Collaboration Award is - #StandWithScience on Coronavirus Vaccines, Pfizer

Finalists included:

  • Carer Well-Being Index: Recognizing and Providing Support for Unpaid Carers, Merck
  • Roche and Regeneron Collaborate to Significantly Increase Global Supply of Investigational Antibody Combination REGEN-COV for COVID-19, Roche
  • OneThree Biotech and Jubilant Therapeutics Collaboration, OneThree Biotech
  • NCD Academy, Viatris

The winner of the Most Valuable Breakthrough/Discovery Award is - REGEN-COV™, Regeneron

Finalists included:

  • ADUHELM, Biogen
  • GAVRETO - Rapid Path to FDA Approval, Blueprint Medicines
  • Gene Writing, Tessera Therapeutics
  • SH-111, Shorla Pharma
  • Development of a New Technology for Obtaining a New Highly Effective Active Substance, JSC Margali
The winner of the Most Valuable Data & Insights Initiative is - OneThree Biotech and Jubilant Therapeutics Collaboration

Finalists included:

  • ImmunoLab - Sanofi Immunology Data Discovery Lab, Sanofi
  • Validating Novel Outcome Measurements – VALINOS, LEO Innovataion Lab - Studies & Me
  • Trial Pathfinder: Using Machine Learning to Advance Inclusive Research, Genentech
  • NMQF Clinical Trial Index and Learning Community, Biogen

The winner of the Most Valuable HCP Initiative Award is - CHIEF-HF: reimagining clinical trials for the future, Janssen

Finalists included:

  • Institute of Leadership Excellence, PharmEvo
  •  ‘Hands-on’ Technical Training in a Virtual World, Organon
  • The AMAZE Disease Management Platform, AstraZeneca
  •  Medtronic PVI Occlusion App, Medtronic
See these projects in more details in this article below.
*Can't view the PDF? Click here
All the presentations from all 40 finalists and winners (from across all categories) will be available to watch at Reuters Events Pharma (11 October, Virtual), where thousands of your peers will join in celebrating all our amazing finalists. 
Reuters Events Pharma 2021 Plenary Pass includes:
  • 40+ presentations from Reuters Events Pharma 2021 Award winners and finalists
  • October 11 plenary sessions – available live and on-demand
  • Live Q/A during sessions
  • Presentations from our solution provider sponsors
  • Virtual exhibition
  • Discussion boards
Fill in the form and see all the finalists presentations at Reuters Events: Pharma 2021 with a FREE plenary pass >>>
Kind regards,
See these finalists presentations at Reuters Events Pharma 2021 with a FREE Plenary Pass

Reuters Events will use this information to contact you about relevant content, products, and services. You may unsubscribe at any time. For more information, check out our Privacy Policy: https://www.thomsonreuters.com/en/privacy-statement.html.

Reuters Events is part of Reuters News & Media Ltd, 5 Canada Square, Canary Wharf, London, E14 5AQ. Registered in England and Wales: 2505735.